M L Tetef
Overview
Explore the profile of M L Tetef including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shibata S, Pezner R, Chu D, Doroshow J, Chow W, Leong L, et al.
Eur J Surg Oncol
. 2004 Jul;
30(6):650-7.
PMID: 15256240
Aim: We describe the feasibility of combining infusional 5-fluorouracil (5-FU) with intraoperative radiation therapy (IORT). Methods: Patients with surgically resectable locally advanced gastrointestinal cancers were treated concurrently during surgery with...
2.
Tetef M, Synold T, Chow W, Leong L, Margolin K, Morgan R, et al.
Clin Cancer Res
. 2001 Jun;
7(6):1569-76.
PMID: 11410492
Dexrazoxane is a bidentate chelator of divalent cations. Pretreatment with short infusions of dexrazoxane prior to bolus doxorubicin has been shown to lessen the incidence and severity of anthracycline-associated cardiac...
3.
Somlo G, Doroshow J, Synold T, Longmate J, Reardon D, Chow W, et al.
Br J Cancer
. 2001 Jun;
84(12):1591-8.
PMID: 11401310
We assessed the feasibility and pharmacokinetics of high-dose infusional paclitaxel in combination with doxorubicin, cyclophosphamide, and peripheral blood progenitor cell rescue. Between October 1995 and June 1998, 63 patients with...
4.
Raschko J, Synold T, Chow W, Coluzzi P, Hamasaki V, Leong L, et al.
Cancer Chemother Pharmacol
. 2000 Dec;
46(5):403-10.
PMID: 11127945
Purpose: In recognition of the variety of available chemotherapeutic modulating agents and their potential to enhance the efficacy of platinum-based therapy, we embarked upon a phase I study to investigate...
5.
Tetef M, Margolin K, Doroshow J, Akman S, Leong L, Morgan Jr R, et al.
Cancer Chemother Pharmacol
. 2000 Jul;
46(1):19-26.
PMID: 10912573
Purpose: To evaluate the pharmacokinetics and toxicity of high-dose intravenous (i.v.) methotrexate (MTX) with leucovorin in patients with meningeal carcinomatosis. Methods: Of 16 eligible patients entered on this study, 13...
6.
Synold T, Tetef M, Doroshow J
Semin Oncol
. 1998 Oct;
25(4 Suppl 10):93-9.
PMID: 9768830
Although originally developed as an antitumor agent in the 1970s, dexrazoxane (DEX) is currently used as a cardioprotective agent in combination with doxorubicin (DOX). Due to concerns about anthracycline-induced cardiotoxicity...